Kudryashov V, Ragupathi G, Kim I J, Breimer M E, Danishefsky S J, Livingston P O, Lloyd K O
Immunology Program, Sloan-Kettering Institute, New York, NY 10021, USA.
Glycoconj J. 1998 Mar;15(3):243-9. doi: 10.1023/a:1006992911709.
Globo H (Fuc alpha1 --> 2Galbeta1 --> 3GalNAcbeta1 --> 3Gal alpha1 --> 4Galbeta1 --> 4Glc) is a carbohydrate structure that shows enhanced expression in many human carcinomas. From mice immunized with a globo H-KLH (keyhole limpet hemocyanin) synthetic conjugate an IgG3 monoclonal antibody (mAb VK-9) was derived that recognizes the globo H structure. Serological analysis showed that the minimal structure recognized by this mAb was the tetrasaccharide sequence Fuc alpha1 --> 2Galbeta1 --> 3GalNAcbeta1 --> 3Gal. An isomeric structure with an internal alphaGalNAc linkage was also recognized but less efficiently. mAb VK-9 did not react with many related structures, such as galactosylgloboside, globoside, H type 1, H type 2 blood group structures or fucosyl-gangliotetraosyl ceramide, but did react weakly with globo A ceramide. Not only did mAb VK-9 react with carbohydrate-protein conjugates but it could also recognize globo H-ceramide and human tumor cells expressing globo H. These results suggest that globo H-KLH could be explored as a vaccine in the treatment of carcinoma patients.
血型抗原H(Fucα1→2Galβ1→3GalNAcβ1→3Galα1→4Galβ1→4Glc)是一种在多种人类癌症中表达增强的碳水化合物结构。用血型抗原H-钥孔血蓝蛋白(KLH)合成偶联物免疫小鼠后,获得了一种识别血型抗原H结构的IgG3单克隆抗体(mAb VK-9)。血清学分析表明,该单克隆抗体识别的最小结构是四糖序列Fucα1→2Galβ1→3GalNAcβ1→3Gal。一种具有内部αGalNAc连接的异构体结构也能被识别,但效率较低。mAb VK-9不与许多相关结构反应,如半乳糖基球蛋白、球蛋白、H1型、H2型血型结构或岩藻糖基神经节四糖神经酰胺,但与血型抗原A神经酰胺反应较弱。mAb VK-9不仅能与碳水化合物-蛋白质偶联物反应,还能识别血型抗原H-神经酰胺和表达血型抗原H的人类肿瘤细胞。这些结果表明,血型抗原H-KLH可作为一种疫苗用于癌症患者的治疗研究。